Logo image of CFLT

CONFLUENT INC-CLASS A (CFLT) Stock Fundamental Analysis

USA - NASDAQ:CFLT - US20717M1036 - Common Stock

22.74 USD
-1.34 (-5.56%)
Last: 10/10/2025, 9:15:55 PM
22.63 USD
-0.11 (-0.48%)
After Hours: 10/10/2025, 9:15:55 PM
Fundamental Rating

4

Overall CFLT gets a fundamental rating of 4 out of 10. We evaluated CFLT against 282 industry peers in the Software industry. CFLT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CFLT is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CFLT was profitable.
In the past year CFLT had a positive cash flow from operations.
In the past 5 years CFLT always reported negative net income.
CFLT had negative operating cash flow in 4 of the past 5 years.
CFLT Yearly Net Income VS EBIT VS OCF VS FCFCFLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

CFLT has a worse Return On Assets (-11.06%) than 63.12% of its industry peers.
CFLT has a worse Return On Equity (-29.31%) than 60.99% of its industry peers.
Industry RankSector Rank
ROA -11.06%
ROE -29.31%
ROIC N/A
ROA(3y)-16.7%
ROA(5y)-21.68%
ROE(3y)-49.78%
ROE(5y)-55.06%
ROIC(3y)N/A
ROIC(5y)N/A
CFLT Yearly ROA, ROE, ROICCFLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Gross Margin, with a value of 74.22%, CFLT is in the better half of the industry, outperforming 63.83% of the companies in the same industry.
CFLT's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for CFLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.29%
GM growth 5Y1.8%
CFLT Yearly Profit, Operating, Gross MarginsCFLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

5

2. Health

2.1 Basic Checks

CFLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
CFLT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CFLT has more shares outstanding
Compared to 1 year ago, CFLT has an improved debt to assets ratio.
CFLT Yearly Shares OutstandingCFLT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
CFLT Yearly Total Debt VS Total AssetsCFLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CFLT has an Altman-Z score of 2.31. This is not the best score and indicates that CFLT is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.31, CFLT is in line with its industry, outperforming 52.13% of the companies in the same industry.
CFLT has a debt to FCF ratio of 66.29. This is a negative value and a sign of low solvency as CFLT would need 66.29 years to pay back of all of its debts.
CFLT has a Debt to FCF ratio (66.29) which is in line with its industry peers.
A Debt/Equity ratio of 1.03 is on the high side and indicates that CFLT has dependencies on debt financing.
With a Debt to Equity ratio value of 1.03, CFLT is not doing good in the industry: 74.47% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 66.29
Altman-Z 2.31
ROIC/WACCN/A
WACC10.99%
CFLT Yearly LT Debt VS Equity VS FCFCFLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 3.98 indicates that CFLT has no problem at all paying its short term obligations.
CFLT has a better Current ratio (3.98) than 82.98% of its industry peers.
CFLT has a Quick Ratio of 3.98. This indicates that CFLT is financially healthy and has no problem in meeting its short term obligations.
CFLT has a Quick ratio of 3.98. This is amongst the best in the industry. CFLT outperforms 82.98% of its industry peers.
Industry RankSector Rank
Current Ratio 3.98
Quick Ratio 3.98
CFLT Yearly Current Assets VS Current LiabilitesCFLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 63.64% over the past year.
Looking at the last year, CFLT shows a very strong growth in Revenue. The Revenue has grown by 23.01%.
Measured over the past years, CFLT shows a very strong growth in Revenue. The Revenue has been growing by 45.10% on average per year.
EPS 1Y (TTM)63.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)23.01%
Revenue growth 3Y35.44%
Revenue growth 5Y45.1%
Sales Q2Q%20.13%

3.2 Future

Based on estimates for the next years, CFLT will show a very strong growth in Earnings Per Share. The EPS will grow by 29.71% on average per year.
The Revenue is expected to grow by 17.07% on average over the next years. This is quite good.
EPS Next Y23.57%
EPS Next 2Y25.78%
EPS Next 3Y29.8%
EPS Next 5Y29.71%
Revenue Next Year19.97%
Revenue Next 2Y18.19%
Revenue Next 3Y17.83%
Revenue Next 5Y17.07%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CFLT Yearly Revenue VS EstimatesCFLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
CFLT Yearly EPS VS EstimatesCFLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 63.17, which means the current valuation is very expensive for CFLT.
Compared to the rest of the industry, the Price/Earnings ratio of CFLT is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.02, CFLT is valued quite expensively.
Based on the Price/Forward Earnings ratio of 47.91, the valuation of CFLT can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as CFLT.
CFLT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.57.
Industry RankSector Rank
PE 63.17
Fwd PE 47.91
CFLT Price Earnings VS Forward Price EarningsCFLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

CFLT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 474.97
EV/EBITDA N/A
CFLT Per share dataCFLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CFLT does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as CFLT's earnings are expected to grow with 29.80% in the coming years.
PEG (NY)2.68
PEG (5Y)N/A
EPS Next 2Y25.78%
EPS Next 3Y29.8%

0

5. Dividend

5.1 Amount

No dividends for CFLT!.
Industry RankSector Rank
Dividend Yield N/A

CONFLUENT INC-CLASS A

NASDAQ:CFLT (10/10/2025, 9:15:55 PM)

After market: 22.63 -0.11 (-0.48%)

22.74

-1.34 (-5.56%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners92.24%
Inst Owner Change0.01%
Ins Owners3.55%
Ins Owner Change0.48%
Market Cap7.84B
Analysts77.95
Price Target25.56 (12.4%)
Short Float %7.92%
Short Ratio2.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.16%
Min EPS beat(2)5.94%
Max EPS beat(2)16.38%
EPS beat(4)4
Avg EPS beat(4)41.96%
Min EPS beat(4)5.94%
Max EPS beat(4)91.45%
EPS beat(8)8
Avg EPS beat(8)128.74%
EPS beat(12)12
Avg EPS beat(12)102.21%
EPS beat(16)16
Avg EPS beat(16)81.23%
Revenue beat(2)1
Avg Revenue beat(2)-0.04%
Min Revenue beat(2)-0.61%
Max Revenue beat(2)0.52%
Revenue beat(4)2
Avg Revenue beat(4)-0.05%
Min Revenue beat(4)-0.61%
Max Revenue beat(4)0.52%
Revenue beat(8)6
Avg Revenue beat(8)0.33%
Revenue beat(12)10
Avg Revenue beat(12)0.81%
Revenue beat(16)14
Avg Revenue beat(16)2.23%
PT rev (1m)-1.36%
PT rev (3m)-12.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.76%
EPS NY rev (1m)0%
EPS NY rev (3m)0.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.26%
Valuation
Industry RankSector Rank
PE 63.17
Fwd PE 47.91
P/S 7.36
P/FCF 474.97
P/OCF 187.45
P/B 7.37
P/tB 8.79
EV/EBITDA N/A
EPS(TTM)0.36
EY1.58%
EPS(NY)0.47
Fwd EY2.09%
FCF(TTM)0.05
FCFY0.21%
OCF(TTM)0.12
OCFY0.53%
SpS3.09
BVpS3.09
TBVpS2.59
PEG (NY)2.68
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.06%
ROE -29.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.22%
FCFM 1.55%
ROA(3y)-16.7%
ROA(5y)-21.68%
ROE(3y)-49.78%
ROE(5y)-55.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.29%
GM growth 5Y1.8%
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 66.29
Debt/EBITDA N/A
Cap/Depr 97.23%
Cap/Sales 2.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.98
Quick Ratio 3.98
Altman-Z 2.31
F-Score6
WACC10.99%
ROIC/WACCN/A
Cap/Depr(3y)148.98%
Cap/Depr(5y)197.88%
Cap/Sales(3y)2.54%
Cap/Sales(5y)2.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y23.57%
EPS Next 2Y25.78%
EPS Next 3Y29.8%
EPS Next 5Y29.71%
Revenue 1Y (TTM)23.01%
Revenue growth 3Y35.44%
Revenue growth 5Y45.1%
Sales Q2Q%20.13%
Revenue Next Year19.97%
Revenue Next 2Y18.19%
Revenue Next 3Y17.83%
Revenue Next 5Y17.07%
EBIT growth 1Y3.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year377.75%
EBIT Next 3Y129.35%
EBIT Next 5Y86.45%
FCF growth 1Y108.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y123.81%
OCF growth 3YN/A
OCF growth 5YN/A